Avery Dennison (Cont’d from Page 7)
Industry Events
Supply Chain Security Act, once fully implemented in November 2023,will require all members of the supply chain to use an electronic, interoperable system that tracks a drug at the unit level throughout the supply chain until it reaches the patient.This will provide pro- tection against exposure to drugs that may be coun- terfeit, stolen, contaminated, or otherwise harmful.The product identifier must be a standardized graphic in both human-readable format and on a machine-read- able data carrier in a 2D data matrix barcode contain- ing the National Drug Code (NDC) plus a unique serial number, lot number, and an expiration date. By adding track-and-trace capabilities to pharma- ceutical and other healthcare products, the label can help better document and communicate regulatory compliance and faster, more precise recalls. RFID and intelligent labeling can be the best way to accom- plish this feat. “Track-and-trace can help monitor temperature and other conditions to ensure drug quality with passive RFID sensors,” commented Keller. “And RFID gives drug makers and pharmacists more effective ways of communicating about correct product use, enabling improved patient compliance.” Avery Dennison has reportedly developed a wide range of portfolios to meet demand across the health- care landscape.The company’s Pharma Security Solu- tion Portfolio features products that overtly show a product has been tampered with.These include fiber tears, sharp tears, frangible and voids. Plus, the Cold Chain and Cryogenic Portfolio can help ensure clear identification of biological materials from collection to storage, transportation and delivery. “Products in this portfolio feature good adhesion to substrates, including PP, glass, PVC and steel/alumi- num, as well as print compatibility with UV flexo and thermal transfer,” stated Keller. “Good conformability for small diameter containers is also important, as is the ability to withstand multiple freeze-thaw cycles. Suitability for autoclave sterilization is critical, as well. To meet demand for smart solutions, Avery Denni- son’s Pharma Intelligent Label Portfolio consists of RFID inlays to create intelligent labels for multiple use cases. These include track-and-trace (consumer safe- ty, authentication and anti-counterfeiting), inventory management (Improved efficiency and more effective product recalls), and consumer engagement (virtual pharmacist, dosage tracking and more). In addition to enhanced product performance, phar- maceutical companies often desire label materials to come with assurances of component change minimi- zation and robust change notification due to the time
SuperCorrExpo 2021 August 8–12, 2021 Orange County Convention Center Orlando, FL
Labelexpo Europe September 21-24, 2021 Brussels Expo Brussels, Belgium CorrExpo 2021 September 27 - 29, 2021 St. Louis, Missouri
FTA Fall Conference October 4-6, 2021 Frisco, TX
Label Congress 2021 September 29-October 1, 2021 Brussels Centre Expo Brussels, Belgium TLMI Annual Meeting October 17-19, 2021 Naples Grande Beach Resort Naples, FL
FTA INFOFLEX 2022 March 14-15, 2022 Fort Worth, Texas Labelexpo Europe April 26-29, 2022 Brussels Centre Expo Brussels, Belgium
Labelexpo Americas September 13-15, 2022 Donald E. Stephens Convention Center Rosemont, IL
FTA Fall Conference October 17-19, 2022 Covington, KY
(Cont’d on Page 14)
Flexo Market News August 30, 2021 13
www.nvpublications.com
Made with FlippingBook. PDF to flipbook with ease